Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is used for advanced Parkinson’s disease treatment to improve the quality of life of patients by alleviating motor symptoms, as well as ...

Tardive dyskinesia (TD) can be addressed by the right intervention even in severe, refractory cases. These cases, characterized by involuntary muscle movements, are most often caused by antipsychotics ...

Trisha Pfluger, M.S., PMP, Chief Scientific Officer, and Nicholas Totagrande, CEO, Juno Biomedical, Inc. talk medical advancement, AI, and next steps for CELLTech ...

Deep brain stimulation has been proven to be an effective treatment for reducing the movement-related symptoms of Parkinson’s disease—and Boston Scientific is aiming to up those efficacy levels even ...

(WTNH) — The Chase Family Movement Disorders Center at the Hartford HealthCare Ayer Neuroscience Institute offers Deep Brain Stimulation (DBS) for the treatment of advanced Parkinson’s disease and ...

The digitization of implanted devices continues apace. On Monday, Abbott announced the launch of its FDA-approved NeuroSphere Virtual Clinic by which patients implanted with the company’s deep brain ...

Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and ...